If they get onto something at Edjudina, Saracen are just up the road for an easy out, then moving onto bigger and better things
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025